GW Pharmaceuticals PLC GWPH, +0.00% said Thursday it has won a unanimous recommendation from a U.S. Food and Drug Administration advisory committee for the approval of its cannabis-derived drug epidiolex. Epidiolex -- which contains cannabidiol (CBD), rather than the psychoactive ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment